Electrocardiographic amplitudes: A new risk factor for sudden death in hypertrophic cardiomyopathy

European Heart Journal

Volumn 31, Issue 4, 2010, Pages 439-449

  Östman Smith, Ingegerd ^a   Wisten, Aase ^b   Nylander, Eva ^c   Bratt, Ewa Lena ^a   Granelli, Anne De Wahl ^a   Oulhaj, Abderrahim ^d   Ljungström, Erik ^e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Athletes; Electrocardiogram; Gender; Hypertrophic cardiomyopathy; Screening; Sudden death

Indexed keywords

ADULT; ARTICLE; ATHLETE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PREDICTOR VARIABLE; PRIORITY JOURNAL; QRS COMPLEX; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH; T WAVE AMPLITUDE; T WAVE INVERSION;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; DEATH, SUDDEN, CARDIAC; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RUNNING; SWIMMING;

EID: 77249144813     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp443     Document Type: Article

References (37)

1. Sugishita Y, Matsuda M, Iida K, Koshinaga J, Ueno M. Sudden cardiac death at exertion. Jpn Circ J 1983;47:562-572.
2. Maron B, Roberts W, McAllister H, Rosing D, Epstein S. Sudden death in young athletes. Circulation 1980;62:218-229.
3. Fananapazir L, Epstein ND. Prevalence of hypertrophic cardiomyopathy and limitations of screening methods. Circulation 1995;92:700-704.
4. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, Mahon NG, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000;36:2212-2218.
5. Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron BJ. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348:295-303. (Pubitemid 36119984)
6. Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodar-one treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Heart 1998;79:331-336.
7. Olivotto I, Maron BJ, Montereggi A, Mazzuoli F, Dolara A, Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999;33: 2044-2051.
8. Elliott PM, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001;357:420-424.
9. Hess OM. Risk stratification in hypertrophic cardiomyopathy. Fact or fiction? J Am Coll Cardiol 2003;42:880-881.
10. Östman-Smith I, Wettrell G, Keeton B, Riesenfeld T, Holmgren D, Ergander U. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 2005;15:632-642.
11. Nugent A, Daubeney P, Chondros P, Carlin J, Cheung M, Wilkinson L, Davis A, Kahler S, Chow C, Wilkinson J, Weintraub R. The epidemiology of childhood car-diomyopathy in Australia. N Engl J Med 2003;348:1639-1646.
12. Ö stman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hyper-trophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 1999;34:1813-1822.
13. Storstein L, Bjornstad H, Hals O, Meen H. Electrocardiographic findings according to sex in athletes and controls. Cardiology 1992;79:227-236.
14. Wisten A, Forsberg H, Krantz P, Messner T. Sudden cardiac death in 15-35-year olds in Sweden during 1992-1999. J Intern Med 2002;252:529-536.
15. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;37:161-186.
16. Siegel RJ, Roberts WC. Electrocardiographic observations in severe aortic valve stenosis: correlative necropsy study to clinical, hemodynamic, and ECG variables demonstrating relation of 12-lead QRS amplitude to peak systolic transaortic pressure gradient. Am Heart J 1982;103:210-221.
17. Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992;20:1180-1186.
18. James AF, Choisy SC, Hancox JC. Recent advances in understanding sex differences in cardiac repolarization. Prog Biophys Mol Biol 2005;94:265-319.
19. Basso C, Thiene G, Corrado D, Buja G, Melacini P, Nava A. Hypertrophic cardi-omyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 2000;31:988-998.
20. Maron BJ, Spirito P, Shen W-K, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NAM, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P. Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy. JAMA 2007;298: 405-412. (Pubitemid 47124061)
21. Thaman R, Gimeno JR, Reith S, Esteban MT, Limongelli G, Murphy RT, Mist B, McKenna WJ, Elliott PM. Progressive left ventricular remodeling in patients with hypertrophic cardiomyopathy and severe left ventricular hypertrophy. J Am Coll Cardiol 2004;44:398-405.
22. Elliott PM, Gimeno JR, Thaman R, Shah J, Ward D, Dickie S, Tome Esteban M, McKenna WJ. Historical trends in reported survival rates in patients with hyper-trophic cardiomyopathy. Heart 2006;92:785-791.
23. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-538.
24. Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of elec-trocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 2005;96:270-275.
25. McKenna WJ, Stewart JT, Nihoyannopoulos P, McGinty F, Davies MJ. Hyper-trophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 1990;63:287-290.
26. Varnava A, Baboonian C, Davison F, de Cruz L, Elliott P, Davies M, McKenna W. A new mutation of the cardiac troponin T gene causing familial hypertrophic car-diomyopathy without left ventricular hypertrophy. Heart 1999;82:621-624.
27. Mayosi BM, Keavney B, Kardos A, Davies CH, Ratcliffe PJ, Farrall M, Watkins H. Electrocardiographic measures of left ventricular hypertrophy show greater her-itability than echocardiographic left ventricular mass. Eur Heart J 2002;23: 1963-1971.
28. Havndrup O, Bundgaard H, Andersen P, Larsen L, Vuust j, Kjeldsen K, Christiansen M. Outcome of clinical versus genetic family screening in hyper-trophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Car-diovasc Res 2002;57:347-357.
29. Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001;10:1215-1220.
30. Kuroda N, Ohnishi Y, Yoshida A, Kimura A, Yokoyama M. Clinical significance of T-wave alternans in hypertrophic cardiomyopathy. Circ J 2002;66:457-462.
31. Yi G, Prasad K, Elliott P, Sharma S, Guo X, McKenna W, Malik M. T wave complexity in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 1998;21:2382-2386.
32. Maron BJ, Roberts WC, Epsetin SE. Sudden death in hypertrophic cardiomyopa-thy: a profile of 78 patients. Circulation 1982;65:1388-1394.
33. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 2001;50:399-408.
34. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.
35. Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension 1995; 25:242-249.
36. Pelliccia A, Di Paolo FM, Corrado D, Buccolieri C, Quattrini FM, Pisicchio C, Spataro A, Biffi A, Granata M, Maron BJ. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 2006;27:2196-2200.
37. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a pre-participation screening program. JAMA 2006;296:1593-1601. (Pubitemid 44515020)